HCP Announces Results for the Fourth Quarter and Year Ended December 31, 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- S&P Global explores potential separation of Capital IQ business
Stifel Downgrades HCP (HCP) to Sell
February 11, 2016 7:17 AM ESTStifel downgraded HCP (NYSE: HCP) from Hold to Sell with a price target of $23.00.
For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.
Shares of HCP closed at $27.21 yesterday.
... MoreUBS Cuts Price Target on HCP, Inc. (HCP) as HCR ManorCare (HCRMC) Faces Difficulties
February 10, 2016 10:36 AM ESTUBS maintained a Buy rating on HCP (NYSE: HCP), and cut the price target to $31.00 (from $41.00). UBS estimates a 30% rent cut would improve coverage fixed charge coverage to 1.4x-1.5x at HRCMC, versus the ~1.1x in guidance for 2016. The higher coverage would provide... More
Hilliard Lyons Downgrades HCP (HCP) to Long-Term Buy
February 10, 2016 9:44 AM ESTHilliard Lyons downgraded HCP (NYSE: HCP) from Buy to Long-Term Buy.
For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.
Shares of HCP closed at $28.33 yesterday.
... MoreMizuho Securities Remains Neutral on HCP, Inc. (HCP) - Cuts PT to $26
February 10, 2016 8:15 AM ESTMizuho Securities reiterated a Neutral rating on HCP (NYSE: HCP), and cut the price target to $26.00 (from $37.00). Mizuho believes that HCP is a sideways mover for now, with some possible volatility related to the sell-off on Wednesday. Mizuho analysts remain negatively-biased, despite... More



